We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approves Merck’s Cholesterol Combo; Critics Cry Foul
FDA Approves Merck’s Cholesterol Combo; Critics Cry Foul
May 10, 2013
In a move that drew disgruntled comments from FDA advisors, the agency May 3 approved Merck’s Liptruzet, a combination of Merck’s Zetia and Pfizer’s Lipitor, to treat hyperlipidemia.